The New York Times identified at least 40 clinics and wellness centers in Mexico offering ibogaine treatments, ranging from luxury operations with medical staff to informal rustic facilities.

Mind-altering substances like psilocybin, LSD, MDMA, and ayahuasca and their therapeutic and cultural use.

First government-funded clinical trials of ibogaine for opioid addiction and PTSD, conducted by the FDA and VA.